Author: News Desk

Item 7.01 Regulation FD.On February 9, 2023, Entrada Therapeutics, Inc. (“Entrada”) issued a press release announcing the closing of the Strategic Collaboration and License Agreement (the “License Agreement”) and Sublicense Agreement (the “Sublicense Agreement”) with Vertex Pharmaceuticals Incorporated (“Vertex”). A copy of the press release is furnished hereto as Exhibit 99.1.The information in this Item…

Read More “8-K Other Events Reg FD – Entrada Therapeutics, Inc. (0001689375) February 09” »

Item 8.01Other Events. On February 9, 2023, Rain Oncology Inc. (the “Company”) will participate in a fireside chat at the Guggenheim Healthcare Talks Oncology Day Conference. A copy of the corporate presentation that will be referenced during such presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by…

Read More “8-K Other Events – Rain Oncology Inc. (0001724979) February 09” »

Item 7.01 Regulation FD Disclosure. On February 9, 2023, Tonix Pharmaceuticals Holding Corp. (the “Company”) announced preclinical data that demonstrates that a single dose vaccination with the Company’s TNX-801 product candidate was effective at protecting non-human primates from infection with monkeypox virus in a publication entitled, “Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination…

Read More “8-K Other Events Reg FD – Tonix Pharmaceuticals Holding Corp. (0001430306) February 09” »

Item 2.02 Results of Operations and Financial Condition. On February 9, 2023, EngageSmart, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein…

Read More “8-K Earnings Reg FD – EngageSmart, Inc. (0001863105) February 09” »

Item 2.02Results of Operations and Financial Condition. On February 9, 2023, Shutterstock, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal period ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this current report and is incorporated herein by reference. In accordance with…

Read More “8-K Earnings Reg FD – Shutterstock, Inc. (0001549346) February 09” »

Item 2.02.Results of Operations and Financial Condition.On February 9, 2023, Philip Morris International Inc. (the “Company”) issued a press release announcing its financial results for the quarter and the fiscal year ended December 31, 2022. The earnings release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference to…

Read More “8-K Earnings – Philip Morris International Inc. (0001413329) February 09” »

Item 2.02 Results of Operations and Financial Condition On February 9, 2023, Veru Inc. issued a press release (the “Press Release”) announcing results for the quarter ended December 31, 2022. A copy of the Press Release is attached as Exhibit 99.1 to this report. The attached Exhibit 99.1 is furnished pursuant to Item 2.02 of…

Read More “8-K Earnings – VERU INC. (0000863894) February 09” »

Item 2.02. Results of Operations and Financial Condition. On February 9, 2023 Bruker Corporation issued a press release announcing financial results as of and for the three months and year ended December 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1. The information furnished in this Current Report on Form…

Read More “8-K Earnings – BRUKER CORP (0001109354) February 09” »